{"text": "Abilify may increase the risk of tardive dyskinesia, a rare but serious side\n\neffect. According to a study published in the Journal of Clinical\n\nPsychopharmacology, approximately 0.1% of patients taking Abilify experience\n\ntardive dyskinesia (3).\n\nQT Interval Prolongation\n\nAbilify may increase the risk of QT interval prolongation, a rare but serious\n\nside effect. According to a study published in the Journal of Clinical\n\nPsychopharmacology, approximately 0.1% of patients taking Abilify experience", "embedding": []}